Tilak Ventures Share Price: Oct 27 Scheme Meeting

Tilak Ventures Ltd has informed BSE that its board will meet on October 27, 2026, to consider and approve a proposed Scheme of Arrangement. The proposal is being considered under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. The company filed the board-meeting intimation with BSE on October 16, 2026. For investors tracking Tilak Ventures share price and corporate actions, the meeting is the immediate disclosed event to watch. The filing does not set out the detailed structure, financial terms, or expected operational effects of the proposed scheme.

Board meeting scheduled for October 27

The Board of Directors is scheduled to convene on Tuesday, October 27, 2026. Its stated agenda is to consider and approve the Scheme of Arrangement. The board may also consider matters that are incidental or consequential to the proposed scheme. The company has listed the planned action in its corporate-actions information as a Scheme of Arrangement dated October 27. At the time of the October 16 intimation, the proposal remained subject to the board's consideration and the required approvals. The notice itself does not confirm that a final scheme has been approved or implemented.

What the BSE disclosure states

Tilak Ventures' disclosure refers specifically to Sections 230 to 232 of the Companies Act, 2013. These provisions provide the legal framework for compromises, arrangements, mergers and related corporate restructuring proposals. The company said the board would consider the scheme along with other applicable provisions of the Act. The exchange filing was made pursuant to the company's disclosure obligations under the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. No named counterparty, asset, business division, share-exchange ratio, or capital restructuring detail was included in the information provided.

Scheme terms have not been disclosed

The current announcement is an intimation of a board meeting rather than a detailed transaction document. It does not quantify any financial impact from the proposal. There are no disclosed figures for consideration, valuation, revenues, debt, equity issuance, or changes in capital structure. The filing also does not identify whether the scheme would involve a merger, demerger, capital reorganisation, or another form of arrangement. As a result, any assessment of the transaction's effect on the company or its shareholders will depend on disclosures issued after the board meeting.

Key dates and disclosed details

Regulatory approvals remain relevant

A scheme considered by a board does not become effective solely through a board resolution. The company has indicated that the proposal is subject to necessary regulatory and statutory approvals. The nature and sequence of those approvals will depend on the final structure of the scheme and the terms eventually disclosed. The available announcement does not provide a timetable for further filings, shareholder approvals, tribunal proceedings, or implementation. Investors should therefore distinguish between the scheduled board consideration and completion of any eventual corporate action.

Recent Tilak Jewels acquisition context

Separate information in the provided company updates states that Tilak Ventures approved an investment to acquire 100% equity in Tilak Jewels Limited. Following completion, Tilak Jewels is expected to become a wholly owned subsidiary of Tilak Ventures. The disclosed consideration was ₹1 crore, based on ₹1 per share, and the transaction was described as a cash deal expected to close within 15 days. Tilak Jewels was incorporated in August 2026 and operates in commodity trading, according to the supplied information. However, the October 16 board-meeting intimation does not state whether the proposed Scheme of Arrangement is connected to this acquisition.

Governance updates reported in September

The supplied company information also refers to shareholder approvals in September 2026. Shareholders approved the re-appointment of independent director Vikash Kulhriya. They also approved the appointment of Jay Bhatt & Associates as secretarial auditor for five years, effective until the annual general meeting for FY 2031-32. These updates are separate from the scheme-meeting notice. They provide context on recent governance-related actions but do not explain the terms or purpose of the proposed arrangement.

Relevance for Tilak Ventures shareholders

The announcement is relevant because a Scheme of Arrangement can potentially affect a listed company's organisational structure, ownership framework, assets, or business operations. Yet the current disclosure gives no basis to quantify such an effect for Tilak Ventures. There is no disclosed impact on earnings, net worth, shareholding, or valuation. Market participants will need the board's subsequent outcome and any detailed scheme document to understand the proposal. Until then, the confirmed information is limited to the meeting date, agenda, legal provisions cited, and the requirement for further approvals.

What to monitor after the meeting

The next relevant update would be a board-outcome disclosure setting out whether the proposal was approved. If a scheme is approved for further action, stakeholders may look for details on its structure, parties involved, financial terms, rationale, and approval process. Any clarification on the relationship between the arrangement and Tilak Ventures' acquisition of Tilak Jewels would also be material, if the company provides it. For now, the October 27 meeting remains the scheduled corporate event. The company has not disclosed a final financial or operational outcome from the proposed Scheme of Arrangement.

Conclusion

Tilak Ventures has called a board meeting on October 27, 2026, to consider a Scheme of Arrangement under Sections 230 to 232 of the Companies Act, 2013. The October 16 BSE filing does not provide transaction terms or quantify financial impact. Investors will need to monitor the board-outcome announcement and any subsequent statutory or regulatory disclosures for further details.